Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatmentfor Parenteral Nutrition Associated Liver Disease (PNALD)10 locations incl. Fountain ValleySponsor: Fresenius KabiSex: All·Age: 1 Day - 17Code: NCT06274788·RecruitingApply to this trial
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoringfor Kidney Transplant Rejection8 locations incl. Los AngelesSponsor: Insight Molecular DiagnosticsSex: All·Age: 18+Code: NCT07060716·RecruitingApply to this trial
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)for Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome8 locations incl. San DiegoSponsor: Ionis Pharmaceuticals, Inc.Sex: Male·Age: 2 - 65Code: NCT06430385·Phase 1, Phase 2·RecruitingApply to this trial
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Studyfor Sepsis, Septic Shock5 locations incl. GainesvilleSponsor: Bluejay Diagnostics, Inc.Sex: All·Age: 22+Code: NCT06654895·RecruitingApply to this trial
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasisfor Diffuse Astrocytoma, IDH-Mutant6 locations incl. Beverly HillsSponsor: Neonc Technologies, Inc.Sex: All·Age: 18+Code: NCT06047379·Phase 1, Phase 2·RecruitingApply to this trial
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancerfor Colorectal Cancer9 locations incl. New HavenSponsor: Criterium, Inc.Sex: All·Age: 18+Code: NCT06992258·Phase 2·RecruitingApply to this trial
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)for Ventricular Tachycardia (VT)6 locations incl. BostonSponsor: Medtronic Cardiac Ablation SolutionsSex: All·Age: 18 - 85Code: NCT06703489·RecruitingApply to this trial
Clinical Outcome Measure at Stryker Spinefor Degenerative Disc Disease7 locations incl. JacksonvilleSponsor: VB Spine, LLCSex: All·Age: 18+Code: NCT06226272·RecruitingApply to this trial
Use of CereGate Therapy for Freezing of Gait in PDfor Parkinson Disease7 locations incl. Redwood CitySponsor: CereGate Inc.Sex: All·Age: 21 - 80Code: NCT05292794·RecruitingApply to this trial
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VTfor Refractory Ventricular Tachycardia5 locations incl. BirminghamSponsor: Thermedical, Inc.Sex: All·Age: 18+Code: NCT05337241·RecruitingApply to this trial
Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infectionfor Central Nervous System Infection3 locations incl. San FranciscoSponsor: Delve Bio, Inc.Sex: All·Age: All agesCode: NCT07435649·RecruitingApply to this trial
A Study of CSTI-500 in Patients With Prader-Willi Syndromefor Prader-Willi Syndrome1 location in NashvilleSponsor: ConSynance TherapeuticsSex: All·Age: 13 - 50Code: NCT07348601·Phase 2·RecruitingApply to this trial
EEG Abnormalities in Adult ICU Patients With High Risk of Deliriumfor Delirium in the Intensive Care Unit1 location in NashvilleSponsor: Ceribell Inc.Sex: All·Age: 18+Code: NCT07485244·RecruitingApply to this trial
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBSfor Short Bowel Syndrome4 locations incl. St LouisSponsor: Zealand PharmaSex: All·Age: 18 - 90Code: NCT07197944·Phase 3·RecruitingApply to this trial
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizuresfor Focal Epilepsy7 locations incl. BoiseSponsor: Rapport Therapeutics Inc.Sex: All·Age: 18 - 70Code: NCT07219407·Phase 2·RecruitingApply to this trial
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platformfor High-risk Cardiac Patients1 location in NashvilleSponsor: Idoven 1903 S.L.Sex: All·Age: 18+·Accepts healthy volunteersCode: NCT07333547·RecruitingApply to this trial
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)for Renal Cell Carcinoma7 locations incl. San FranciscoSponsor: Merck Sharp & Dohme LLCSex: All·Age: 18 - 120Code: NCT07049926·Phase 1, Phase 2·RecruitingApply to this trial
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) Systemfor Tricuspid Regurgitation6 locations incl. TucsonSponsor: Laplace Interventional, IncSex: All·Age: 22 - 90Code: NCT06183684·RecruitingApply to this trial
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemiafor X-linked Hypophosphatemia5 locations incl. San FranciscoSponsor: Kyowa Kirin Co., Ltd.Sex: All·Age: 18 - 65Code: NCT06525636·Phase 1, Phase 2·RecruitingApply to this trial
Met Non Small Cell Cancer Registry (MOMENT)for Cancer3 locations incl. Fort LauderdaleSponsor: EMD Serono Research & Development Institute, Inc.Sex: All·Age: All agesCode: NCT05376891·RecruitingApply to this trial
Prospective Clinical Assessment Study in Children With Hypochondroplasiafor Hypochondroplasia8 locations incl. OaklandSponsor: QED Therapeutics, a BridgeBio companySex: All·Age: 30 Months - 16Code: NCT06410976·RecruitingApply to this trial
Otoferlin Gene-mediated Hearing Loss Natural History Studyfor Sensorineural Hearing Loss, Bilateral4 locations incl. Iowa CitySponsor: Akouos, Inc.Sex: All·Age: Up to 44Code: NCT05572073·RecruitingApply to this trial
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophyfor Multiple System Atrophy6 locations incl. Los AngelesSponsor: Dasher Neuroscience Inc.Sex: All·Age: 30+Code: NCT06848231·Phase 2·RecruitingApply to this trial
Pounce™ Thrombectomy System Retrospective Registryfor Peripheral Arterial Disease9 locations incl. PeoriaSponsor: SurModics, Inc.Sex: All·Age: 18+Code: NCT05868161·RecruitingApply to this trial
Trisol System EFS Studyfor Tricuspid Regurgitation7 locations incl. Los AngelesSponsor: Trisol MedicalSex: All·Age: 18+Code: NCT04905017·RecruitingApply to this trial
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registryfor Cesarean Delivery34 locations incl. Little RockSponsor: Yale UniversitySex: Female·Age: 15 - 55·Accepts healthy volunteersCode: NCT06030063·RecruitingApply to this trial
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adultsfor Cognitive Impairment, Mild102 locations incl. BirminghamSponsor: Duke UniversitySex: All·Age: 75+·Accepts healthy volunteersCode: NCT04262206·Phase 4·RecruitingApply to this trial
HEALEY ALS Platform Trial - Master Protocolfor Amyotrophic Lateral Sclerosis81 locations incl. PhoenixSponsor: Merit E. Cudkowicz, MDSex: All·Age: 18+Code: NCT04297683·Phase 2, Phase 3·RecruitingApply to this trial
Fecal Microbiota Transplant National Registryfor Fecal Microbiota Transplantation52 locations incl. PhoenixSponsor: American Gastroenterological AssociationSex: All·Age: All agesCode: NCT03325855·RecruitingApply to this trial
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)for Optic Neuritis33 locations incl. ScottsdaleSponsor: Mayo ClinicSex: All·Age: 18+Code: NCT07100990·Phase 3·RecruitingApply to this trial
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulatorsfor Cystic Fibrosis68 locations incl. BirminghamSponsor: Nicole HamblettSex: All·Age: 12+Code: NCT06504589·RecruitingApply to this trial
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohortfor Huntington's Disease62 locations incl. BirminghamSponsor: CHDI Foundation, Inc.Sex: All·Age: 18+·Accepts healthy volunteersCode: NCT01574053·RecruitingApply to this trial
Gastroschisis Outcomes of Delivery (GOOD) Studyfor Gastroschisis38 locations incl. PhoenixSponsor: Medical College of WisconsinSex: Female·Age: 18+Code: NCT02774746·RecruitingApply to this trial
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Networkfor Genetic Disease33 locations incl. BirminghamSponsor: National Human Genome Research Institute (NHGRI)Sex: All·Age: 1 Month - 100·Accepts healthy volunteersCode: NCT02450851·RecruitingApply to this trial
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANTfor Post Operative Surgical Site Infection31 locations incl. Redwood CitySponsor: Major Extremity Trauma Research ConsortiumSex: All·Age: 18 - 64Code: NCT04678154·Phase 3·RecruitingApply to this trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancerfor Breast Neoplasms42 locations incl. BirminghamSponsor: QuantumLeap Healthcare CollaborativeSex: All·Age: 18+Code: NCT01042379·Phase 2·RecruitingApply to this trial
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomesfor Metastatic Ewing Sarcoma17 locations incl. BirminghamSponsor: H. Lee Moffitt Cancer Center and Research InstituteSex: All·Age: 1+Code: NCT07194044·Phase 1·RecruitingApply to this trial
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissuefor Pediatric Sarcoma, Refractory22 locations incl. South BirminghamSponsor: Nationwide Children's HospitalSex: All·Age: 2 - 40Code: NCT05634369·Phase 1, Phase 2·RecruitingApply to this trial
Rapid Evacuation and Access of Cerebral Hemorrhage Trialfor Stroke Hemorrhagic21 locations incl. Little RockSponsor: Emory UniversitySex: All·Age: 18 - 70Code: NCT06870812·RecruitingApply to this trial
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancerfor Stage III Ovarian CancerDrug: Niraparib59 locations incl. DuarteSponsor: GOG FoundationSex: Female·Age: 18+Code: NCT05659381·Phase 3·RecruitingApply to this trial